| 1. |
Vouloumanou EK, Rafailidis PI, Falagas ME. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol, 2012, 19(1): 14-20.
|
| 2. |
Gavin C, Langan Y, Hutchinson M. Cranial and peripheral neuropathy due to Epstein-Barr virus infection. Postgrad Med J, 1997, 73(861): 419-420.
|
| 3. |
Flanagan P, Hawkins SA, Bryars JH. Infectious mononucleosis with cranial nerve palsies. Ulster Med J, 1987, 56(1): 69-71.
|
| 4. |
Brizzi KT, Lyons JL. Peripheral nervous system manifestations of infectious diseases. Neurohospitalist, 2014, 4(4): 230-240.
|
| 5. |
Price AM, Luftig MA. To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and Consequences for B cell tumorigenesis. PLoS Pathog, 2015, 11(3): e1004656.
|
| 6. |
Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood, 2011, 117(22): 5835-5849.
|
| 7. |
Balfour HH Jr, Odumade OA, Schmeling DO, et al. Behavioral,virologic. and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis, 2013, 207(1): 80-88.
|
| 8. |
Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev, 2011, 24(1): 193-209.
|
| 9. |
盧家桀, 唐光敏, 唐紅. 慢性活動性 EB 病毒感染臨床分析. 華西醫學, 2014, 29(2): 282-285.
|
| 10. |
Fujiwara S, Kimura H, Imadome K, et al. Current research on chronic active Epstein-Barr virus infection in Japan. Pediatr Int, 2014, 56(2): 159-166.
|
